FdaApplication
ANDA 204860
Identifiers
- fda_app_no: ANDA204860
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2019-02-15 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PROCHLORPERAZINE EDISYLATE | PROCHLORPERAZINE EDISYLATE | EQ 5MG BASE/ML | INJECTABLE;INJECTION |
1 product